Frederick biotech Veralox Therapeutics raises $5.4M to support drug development, trials - Baltimore Business Journal

Veralox specializes in developing drugs to address unmet medical needs. It is currently working on therapies to target type 1 diabetes and a medication-induced immune disorder.